Yüklüyor......
Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer
Metabolic reprogramming is increasingly recognised as one of the defining hallmarks of tumorigenesis. There is compelling evidence to suggest that endometrial cancer develops and progresses in the context of profound metabolic dysfunction. Whilst the incidence of endometrial cancer continues to rise...
Kaydedildi:
| Yayımlandı: | Metabolites |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7463916/ https://ncbi.nlm.nih.gov/pubmed/32751940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo10080314 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|